Valentina Tesori

Department of Gastroenterology and Internal Medicine, Catholic University, Rome. Italy.

14 publications 2005 – 2017

What does Valentina Tesori research?

Valentina Tesori studies how different types of stem cells function and their potential in treating diseases. She primarily focuses on stem cells in the small intestine and colon cancer stem cells. Her research examines how small intestinal stem cells maintain a balance between self-renewal and differentiation, which is crucial for healing and responding to injuries. Additionally, she explores colon cancer stem cells, which are believed to play a key role in tumor formation and growth, aiming to find targeted treatments for colon cancer. Furthermore, Tesori investigates how mesenchymal stem cells can be utilized to heal liver injuries, highlighting their ability to transform into liver cells and improve liver function.

Key findings

  • Small intestinal stem cells operate from a region called the crypt, receiving signals that help them stay healthy and respond to injury, which is essential for effective treatments of intestinal disorders.
  • Research indicates that understanding colon cancer stem cells can lead to targeted drug development, potentially improving treatment outcomes for patients with colon cancer.
  • Mesenchymal stem cells have shown promise in lab experiments for treating severe liver failure by reducing inflammation and improving liver function.

Frequently asked questions

Does Dr. Tesori study intestinal diseases?
Yes, she focuses on small intestinal stem cells and their role in treating intestinal disorders.
What types of cancer does Dr. Tesori research?
She studies colon cancer, particularly the role of colon cancer stem cells in tumor growth.
Are her studies relevant for liver disease patients?
Absolutely, her research on mesenchymal stem cells aims at improving treatments for liver injuries and severe liver failure.

Publications in plain English

May Gender or Ethnicity Affect Delta Over Baseline Values Obtained by 13-C Urea Breath Test?

2017

Reviews on recent clinical trials

Petruzziello C, Sinatti D, Gnarra M, Migneco A, Tesori V +4 more

Plain English
This study looked at how gender and ethnicity might influence the results of the 13C-urea breath test (UBT), which checks for H. pylori infections in adults. Out of nearly 3,000 patients, 23.4% tested positive for H. pylori, with men more likely to be infected (29%) than women (22%). Additionally, women had higher test results indicating bacterial load than men, leading researchers to suggest that hormonal differences could play a role in these results. Who this helps: This information benefits doctors assessing and treating H. pylori infections in adults, particularly in understanding differences between genders.

PubMed

Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome.

2016

Disease markers

Gervasoni J, Schiattarella A, Giorgio V, Primiano A, Russo C +5 more

Plain English
This study examined a new quick and effective method for measuring two sugars, lactulose and mannitol, in urine to evaluate how well the intestines are functioning in children with irritable bowel syndrome (IBS). The researchers found that the lactulose/mannitol ratio in children with IBS was significantly higher than in those without the condition, indicating a potential problem with intestinal barrier function. This matters because it provides a way to diagnose and understand gut issues in these pediatric patients, paving the way for better treatments. Who this helps: Patients with irritable bowel syndrome and their doctors.

PubMed

Helicobacter pylori infection is associated with high methane production during lactulose breath test.

2016

European review for medical and pharmacological sciences

Del Zompo F, Ojetti V, Feliciani D, Mangiola F, Petruzziello C +4 more

Plain English
This study looked at how an infection with Helicobacter pylori (H. pylori) relates to the production of methane gas in patients undergoing a specific breath test. Researchers found that 47.2% of patients with H. pylori produced higher levels of methane, compared to 26% of those without the infection. This matters because it suggests that H. pylori may affect the balance of bacteria in the gut, which could lead to digestive issues. Who this helps: This information benefits patients experiencing gastrointestinal symptoms and doctors treating them.

PubMed

High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.

2015

The Journal of pathology

Puglisi MA, Cenciarelli C, Tesori V, Cappellari M, Martini M +5 more

Plain English
This study looked at how a substance called nitric oxide (NO), produced by a specific enzyme in the body, affects certain cancer cells in colon cancer. The researchers found that colon cancer stem cells that produced more NO were better at forming tumors. When they reduced NO production, either with drugs or by changing the genes of the cells, the ability of these cancer cells to grow tumors dropped significantly—by more than 50% in some tests. This matters because understanding how NO helps cancer cells can lead to new ways to treat colon cancer by targeting this process. Who this helps: Patients with colon cancer may benefit from new treatment options that target nitric oxide production.

PubMed

The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing.

2015

Scientific reports

Tesori V, Piscaglia AC, Samengo D, Barba M, Bernardini C +8 more

Plain English
This study looked at how the cancer drug Sorafenib affects liver cancer cells. Researchers found that while Sorafenib alone had a limited effect on killing these cells, it caused damage to their mitochondria and increased harmful molecules that lead to cell death. When the supply of glucose was cut off or when a specific glycolysis blocker was used, the effectiveness of Sorafenib in killing the cancer cells increased significantly, highlighting a potential strategy to overcome resistance to the drug. Who this helps: This research helps cancer patients, especially those with liver cancer, by providing insights for more effective treatment options.

PubMed

Tumor initiating cells and chemoresistance: which is the best strategy to target colon cancer stem cells?

2014

BioMed research international

Paldino E, Tesori V, Casalbore P, Gasbarrini A, Puglisi MA

Plain English
This study looked at cancer stem cells (CSCs) in colon cancer, which are special cells that make the cancer resistant to chemotherapy. The researchers found that specific strategies to target these cells could help make treatments more effective, especially by influencing certain genes that help these CSCs survive and grow. Understanding how these cells work and their unique metabolism might lead to better overall cancer treatments. Who this helps: This research benefits patients with metastatic colon cancer who struggle with treatment resistance.

PubMed

Lim mineralization protein is involved in the premature calvarial ossification in sporadic craniosynostoses.

2013

Bone

Lattanzi W, Barba M, Novegno F, Massimi L, Tesori V +6 more

Plain English
This study looked at a type of head bone disorder called sporadic craniosynostosis, where one of the skull seams closes too early. Researchers found that cells from these prematurely fused skull seams showed a stronger ability to form bone compared to normal seams, with specific proteins that drive bone growth being significantly more active. By reducing the levels of a protein called LIM mineralization protein (LMP), they were able to make these cells act more normally, suggesting that LMP plays a key role in the premature bone growth usually seen in this condition. Who this helps: This research can help doctors treating children with craniosynostosis by providing new insights into the underlying biology of the condition.

PubMed

Colon cancer stem cells: controversies and perspectives.

2013

World journal of gastroenterology

Puglisi MA, Tesori V, Lattanzi W, Gasbarrini GB, Gasbarrini A

Plain English
This study looked at colon cancer stem cells (CSCs), which are a specific type of cell believed to play a key role in how colon cancer starts and grows. The researchers reviewed recent findings and highlighted that understanding how these cells work can help in developing better targeted treatments. Their insights could lead to new drugs that specifically target CSCs, improving cancer care. Who this helps: This benefits patients with colon cancer, as it may lead to more effective treatments.

PubMed

Update on small intestinal stem cells.

2013

World journal of gastroenterology

Tesori V, Puglisi MA, Lattanzi W, Gasbarrini GB, Gasbarrini A

Plain English
This research paper examines stem cells in the small intestine, specifically looking at how they maintain balance between renewing themselves and developing into different cell types. The authors found that these stem cells operate from a base area called the crypt, where they receive signals from nearby cells that help them stay healthy and respond to injury. Understanding how these stem cells work is important because it can lead to better treatments for intestinal disorders. Who this helps: This helps patients with intestinal diseases and doctors treating them.

PubMed

Therapeutic implications of mesenchymal stem cells in liver injury.

2011

Journal of biomedicine & biotechnology

Puglisi MA, Tesori V, Lattanzi W, Piscaglia AC, Gasbarrini GB +2 more

Plain English
This study looked at how mesenchymal stem cells (MSCs) could be used to treat liver injuries. Researchers found that MSCs can help by turning into liver cells, reducing inflammation, preventing liver cell death, and improving liver function. They noted promising results in lab experiments for conditions like severe liver failure, but there are still challenges before MSCs can be widely used in hospitals. Who this helps: This research benefits patients with liver diseases, particularly those facing severe liver failure.

PubMed

Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance.

2010

Proceedings of the National Academy of Sciences of the United States of America

Ranieri SC, Fusco S, Panieri E, Labate V, Mele M +7 more

Plain English
This study looked at a protein called p66shcA and its role in obesity and insulin resistance, which are linked to type II diabetes. Researchers found that mice without this protein were leaner and lived longer, showing a significant improvement in their ability to control glucose levels, even though their insulin levels and weight didn't change. This is important because targeting p66shcA could help develop new treatments for preventing obesity and type II diabetes. Who this helps: Patients with obesity and type II diabetes.

PubMed

Nutrient withdrawal rescues growth factor-deprived cells from mTOR-dependent damage.

2010

Aging

Panieri E, Toietta G, Mele M, Labate V, Ranieri SC +7 more

Plain English
This study looked at how removing certain nutrients, like glucose and amino acids, can protect cells from damage typically caused by lack of growth factors. Researchers found that when they deprived cells of these nutrients, the cells survived better, showing up to 70% less cell death compared to untreated cells. This is important because it suggests that targeted nutrient withdrawal could help prevent cell damage related to diabetes and aging, potentially leading to new treatment strategies. Who this helps: This benefits patients with diabetes and age-related diseases.

PubMed

Establishment of cancer cell lines from rat hepatocholangiocarcinoma and assessment of the role of granulocyte-colony stimulating factor and hepatocyte growth factor in their growth, motility and survival.

2009

Journal of hepatology

Piscaglia AC, Shupe TD, Pani G, Tesori V, Gasbarrini A +1 more

Plain English
This study focused on creating cancer cell lines from liver tumors in rats to understand how specific growth factors, G-CSF and HGF, affect the growth and movement of these cells. Researchers successfully developed six cell lines from tumors and found that HGF helped the cancer cells survive, while G-CSF promoted their growth and movement. These findings are significant because they could lead to new treatments targeting these factors in liver cancer. Who this helps: This benefits researchers and doctors looking for more effective therapies for liver cancer patients.

PubMed

Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation.

2005

Brain research

Cosi C, Waget A, Rollet K, Tesori V, Newman-Tancredi A

Plain English
This study looked at how different antipsychotic medications affect brain damage caused by kainic acid in mice. Researchers found that clozapine, ziprasidone, and aripiprazole significantly reduced the size of brain lesions by 61%, 59%, and 73%, respectively, while haloperidol had no effect. These findings highlight the protective role of the 5-HT1A receptor in preventing brain damage, which could lead to better treatment options for conditions like schizophrenia. Who this helps: This helps patients with schizophrenia and other related disorders.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.